Publications
PEER-REVIEWED PUBLICATIONS
1. Abdollah F, Sun M, Jeldres C, Schmitges J, Thuret R, Djahangirian O, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. BJU Int. 2011 Aug 2. PMID: 21810161
2. Roscigno M, Brausi M, Heidenreich A, Lotan Y, Margulis V, Shariat SF, Van Poppel H, Zigeuner R: Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011 Jul 14. PMID: 21798659
3. Abdollah F, Schmitges J, Sun M, Thuret R, Djahangirian O, Jeldres C, Shariat SF, Graefen M, Perrotte P, Montorsi F, Karakiewicz PI: Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study. J Urol. 2011 Jul 23. PMID:21788051
4. Matsushita K, Cha EK, Matsumoto K, Baba S, Chromecki TF, Fajkovic H, Sun M, Karakiewicz PI, Scherr DS, Shariat SF: Immunohistochemical biomarkers for bladder cancer prognosis. Int J Urol. 2011 Jul 20. PMID: 21771101
5. Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Cancer-Specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large north american population-based cohort. Eur Urol. 2011 Jun 29. [Epub ahead of print] PMID: 21741762
6. Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, Pantuck AJ, Zigeuner R, Karakiewicz PI: Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011 Jun 30. [Epub ahead of print] PMID: 21741163
7. Shariat SF, Patschan O, Chade DC, Karakiewicz PI, Ashfaq R, Lotan Y, Hotakainen K, Stenman UH, Bjartell A.: Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder. World J Urol. 2011 Jul 8. [Epub ahead of print] PMID: 21739120
8. Sonpavde G, Shariat SF: Preoperative chemotherapy for bladder cancer: A standard waits to be optimally deployed. Cancer. 2011 [Epub ahead of print] PMID: 21732335
9. Chromecki TF, Bensalah K, Remzi M, Verhoest G, Cha EK, Scherr DS, Novara G, Karakiewicz PI, Shariat SF: Prognostic factors for upper urinary tract urothelial carcinoma. Nat Rev Urol. 2011 [Epub ahead of print] PMID: 21727942
10. Jerónimo C, Bastian PJ, Bjartell A, Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG, Shariat SF: Epigenetics in prostate cancer: biologic and clinical relevance. Eur Urol. 2011 Jun 22. [Epub ahead of print] PMID: 21719191
11. Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V: Urothelial carcinoma at the uretero-enteric junction: Multi-center evaluation of oncologic outcomes after radical nephroureterectomy. Urol Oncol. 2011 Jun 23. [Epub ahead of print] PMID: 21704538
12. Abdollah F, Sun M, Schmitges J, Thuret R, Djahangirian O, Jeldres C, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study. Ann Surg Oncol. 2011 Jun 24. [Epub ahead of print] PMID: 21701925
13. Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ: Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with non muscle-invasive bladder cancer and negative cytology: A decision-curve analysis. Cancer. 2011 Jul 1;117(13):2892-7. PMID: 21692050
14. Tilki D, Burger M, Dalbagni G, Grossman HB, Hakenberg OW, Palou J, Reich O, Rouprêt M, Shariat SF, Zlotta AR: Urine markers for detection and surveillance of non-muscle-invasive bladder cancer. Eur Urol. 2011 Jun 12. [Epub ahead of print] PMID: 21684071
15. Verhoest G, Shariat SF, Chromecki TF, Raman JD, Margulis V, Novara G, Seitz C, Remzi M, Rouprêt M, Scherr DS, Bensalah K: Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol. 2011 Jun 17. [Epub ahead of print] PMID: 21681525
16. Chromecki TF, Cha EK, Shariat SF: Stage pT0 after radical cystectomy: are all patients equal?
Eur Urol. 2011 Jun 7. PMID: 21665358
17. Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF: Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int. 2011 Jun 9. [Epub ahead of print] PMID: 21659717
18. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF: Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011 Jun 9. [Epub ahead of print] PMID: 21656173
19. Abdollah F, Sun M, Thuret R, Abdo A, Morgan M, Jeldres C, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.: The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study. Cancer Causes Control. 2011 Jun 5. [Epub ahead of print] PMID: 21643929
20. Cha EK, Ng CK, Jeun B, Dunning A, Reifsnyder JE, Dipietro JR, Mazumdar M, Shih G, Auh YH, Del Pizzo JJ, Shariat SF, Scherr DS.: Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy. World J Urol. 2011 May 21. [Epub ahead of print] PMID: 21604019
21. Favaretto RL, Shariat SF, Savage C, Godoy G, Chade DC, Kaag M, Bochner BH, Coleman J, Dalbagni G.: Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma. BJU Int. 2011 Jun 1. doi: 10.1111/j.1464-410X.2011.10288.x. [Epub ahead of print] PMID:21631698
22. Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ, Bjartell A.: Tumor markers in prostate cancer I: blood-based markers. Acta Oncol. 2011 Jun;50 Suppl 1:61-75. PMID: 21604943
23. Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G: No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World J Urol. 2011 Jun 1. [Epub ahead of print] PMID: 21630120
24. Ehdaie B, Chromecki TF, Lee RK, Lotan Y, Margulis V, Karakiewicz PI, Novara G, Raman JD, Ng C, Lowrance WT, Scherr DS, Shariat SF: Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma. J Urol. 2011 May 13. [Epub ahead of print] PMID: 21571333
25. Sun M, Abdollah F, Budaüs L, Liberman D, Tian Z, Morgan M, Johal R, Schmitges J, Shariat SF, Montorsi F, Greafen M, Perrotte P, Karakiewicz PI: Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study. Ann Surg Oncol. 2011 Apr 21. [Epub ahead of print] PMID: 21509630
26. Lee R, Ng CK, Shariat SF, Borkina A, Guimento R, Brumit KF, Scherr DS.: The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy. BJU Int. 2011 Apr 18. [Epub ahead of print] PMID: 21501370
27. Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF: Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011 Apr 20. [Epub ahead of print] PMID: 21507184
28. Abdollah F, Sun M, Briganti A, Thuret R, Schmitges J, Gallina A, Suardi N, Capitanio U, Salonia A, Shariat SF, Perrotte P, Rigatti P, Montorsi F, Karakiewicz PI.: Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy. BJU Int. 2011 Apr 20. [Epub ahead of print] PMID:21507189
29. Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF: Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol. 2011 Apr 17. [Epub ahead of print]
30. Abdollah F, Sun M, Thuret R, Schmitges J, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study. Ann Surg Oncol. 2011 Apr 16. [Epub ahead of print]
31. Abdollah F, Sun M, Shariat SF, Schmitges J, Djahangirian O, Tian Z, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI: The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment. J Urol. 2011 Apr 13. [Epub ahead of print]
32. Abdollah F, Schmitges J, Sun M, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI: A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study. Prostate. 2011 Apr 7. doi: 10.1002/pros.21376. [Epub ahead of print]
33. Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. 2011 Apr 7. [Epub ahead of print
34. Zlotta AR, Roumeguere T, Kuk C, Alkhateeb S, Rorive S, Lemy A, van der Kwast TH, Fleshner NE, Jewett MA, Finelli A, Schulman C, Lotan Y, Shariat SF, Nortier J: Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer. Eur Urol. 2011 Mar 30. [Epub ahead of print] PMID: 21458152
35. Chade DC, Shariat SF, Cronin AM, Savage CJ, Karnes RJ, Blute ML, Briganti A, Montorsi F, van der Poel HG, Van Poppel H, Joniau S, Godoy G, Hurtado-Coll A, Gleave ME, Dall'oglio M, Srougi M, Scardino PT, Eastham JA.: Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011 Mar 17. [Epub ahead of print] PMID: 21420229
36. Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.: The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma. J Endourol. 2011 Mar 9. PMID: 21388245
37. Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI.: Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: A survival analysis. Cancer. 2011 Mar 8. doi: 10.1002/cncr.25969. PMID: 21387261
38. Thuret R, Sun M, Abdollah F, Schmitges J, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.: Conditional survival predictions after surgery for patients with penile carcinoma. Cancer. 2011 Feb 24. PMID: 21360525
39. Abdollah F, Sun M, Schmitges J, Thuret R, Djahangirian O, Jeldres C, Tian Z, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI. Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study. Ann Surg Oncol. 2011 Feb 23. [Epub ahead of print] PMID: 21347778
40. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF.: Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. J Urol. 2011 Apr;185(4):1216-21. Epub 2011 Feb 22. PMID: 21334687
41. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Kabbani W, Langner C, Guo CC, Roscigno M, Montorsi F,Bolenz C, Kassouf W, Margulis V. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int. 2011 Feb 18. [Epub ahead of print] PMID: 21332905.
42. Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Steinberg G, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 2011 Feb 14. [Epub ahead of print] PMID: 21320275.
43. Youssef R, Shariat S, Kapur P, Kabbani W, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y: Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder. J Urol. 2011 Jan 20. [Epub ahead of print] PMID: 21255800.
44. Liberman D, Lughezzani G, Sun M, Alasker A, Thuret R, Abdollah F, Budaus L, Widmer H, Graefen M, Montorsi F, Shariat SF, Perrotte P, Karakiewicz PI: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder. Urology. 2011 Jan 20. [Epub ahead of print] PMID: 21256568.
45. Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G: Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. 2011 Jan 20. [Epub ahead of print] PMID: 21249372.
46. Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP: Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int. 2011 Jan 18. [Epub ahead of print] PMID: 21244604.
47. Shariat SF, Savage C, Chromecki TF, Sun M, Scherr DS, Lee RK, Lughezzani G, Remzi M, Marberger MJ, Karakiewicz PI, Vickers AJ: Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis. Cancer. 2011 Jan 10. [Epub ahead of print]PMID: 21225855
48. Mazzola CR, Ghoneim T, Shariat SF: [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].Prog Urol. 2011 Jan;21(1):1-10. Epub 2010 Aug 14. French. PMID: 21193139
49. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Montorsi F, Bolenz C, Margulis V.: Prognostic Effect of Urinary Bladder Carcinoma In Situ on Clinical Outcome of Subsequent Upper Tract Urothelial Carcinoma. Urology. 2010 Dec 15. PMID: 21167566
50. Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF.: Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol. 2010 Dec 16. PMID: 21167527
51. Thuret R, Sun M, Abdollah F, Budaus L, Lughezzani G, Liberman D, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.: Tumor grade improves the prognostic ability of American Joint Committee on cancer stage in patients with penile carcinoma. J Urol. 2010 Dec 16. PMID: 21167526
52. Ahallal Y, Shariat SF, Chade DC, Mazzola C, Reuter VE, Sandhu JS, Laudone VP, Touijer KA, Guillonneau BD.: Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer. BJU Int. 2010 Dec 16. PMID: 21166755
53. Budäus L, Abdollah F, Sun M, Johal R, Morgan M, Thuret R, Zorn KC, Lughezzani G, Isbarn H, Haese A, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI.: The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study. BJU Int. 2010 Dec 13. PMID: 21156018
54. Sfakianos J, Shariat SF, Favaretto RL, Rioja J, Herr HW: Impact of smoking on outcomes after intravesical Bacillus Calmette-Guérin therapy for urothelial carcinoma not invading muscle of the bladder. BJU Int. 2010 Nov 29. [Epub ahead of print] PMID: 2111461
55. Youssef RF, Shariat SF, Kapur P, Kabbani W, Ghoneim T, King E, Cockburn A, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y. Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder. Hum Pathol. 2010 Nov 25. [Epub ahead of print] PMID: 21111452.
56. Sun M, Abdo A, Abdollah F, Schmitges J, Thuret R, Jeldres C, Shariat SF, Perrotte P, Karakiewicz PI. Management of upper urinary tract urothelial carcinoma. Expert Rev Anticancer Ther. 2010 Dec; PMID: 21110761.
57. Youssef R, Kapur P, Kabbani W, Shariat SF, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression. BJU Int. 2010 Nov 24.[Epub ahead of print] PMID: 21105986.
58. Lowrance WT, Tarin TV, Shariat SF. Evidence-based comparison of robotic and open radical prostatectomy. Scientific World Journal. 2010 Nov 16; PMID: 21103791.
59. Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE,Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU Int. 2010 Nov 19.[Epub ahead of print] PMID: 21087453.
60. Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int. 2010 Nov 15.[Epub ahead of print] PMID: 21078048.
61. Mir C, Shariat SF, Van Der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, Van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR. Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int. 2010 Nov 10.[Epub ahead of print] PMID: 21070579.
62. Yee DS, Shariat SF, Lowrance WT, Maschino AC, Savage CJ, Cronin AM, Scardino PT, Eastham JA. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens. BJU Int. 2010 Nov 2.[Epub ahead of print] PMID: 21050364.
63. Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI. Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend Analysis. Eur Urol. 2010 Oct 27. [Epub ahead of print] PMID: 21035250.
64. Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A, Shariat SF, Perrotte P, Rigatti P, Montorsi F, Karakiewicz PI. A Competing-Risks Analysis of Survival After Alternative Treatment Modalities for Prostate Cancer Patients: 1988-2006. Eur Urol. 2010 Oct 14. [Epub ahead of print] PMID: 20965646.
65. Budäus L, Sun M, Abdollah F, Zorn KC, Morgan M, Johal R, Liberman D, Thuret R, Isbarn H, Salomon G, Haese A, Montorsi F, Shariat SF, Perrotte P, Graefen M, Karakiewicz PI. Impact of Surgical Experience on In-Hospital Complication Rates in Patients Undergoing Minimally Invasive Prostatectomy: A Population-Based Study. Ann Surg Oncol. 2010 Oct 16. [Epub ahead of print] PMID: 20953720.
66. Budäus L, Abdollah F, Sun M, Morgan M, Johal R, Thuret R, Zorn KC, Isbarn H, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI. Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends. J Urol. 2010 Dec; Epub 2010 Oct 16. PMID: 20952010.
67. Barbieri CE, Lotan Y, Lee RK, Sonpavde G, Karakiewicz PI, Robinson B, Scherr DS, Shariat SF. Tissue-based molecular markers for bladder cancer. Minerva Urol Nefrol. 2010 Sep; PMID: 20940694.
68. Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. 2010 Oct 6. [Epub ahead of print] PMID: 20933445.
69. Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, Capitanio U, Shariat SF, Arjane P, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. Urology. 2010 Oct; PMID: 20932408.
70. Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2010 Oct 1. [Epub ahead of print] PMID: 20886219.
71. Chun FK, Epstein JI, Ficarra V, Freedland SJ, Montironi R, Montorsi F, Shariat SF, Schröder FH, Scattoni V. Optimizing Performance and Interpretation of Prostate Biopsy: A Critical Analysis of the Literature. Eur Urol. 2010 Sep 4.[Epub ahead of print] PMID: 20884114.
72. Liberman D, Alasker A, Sun M, Ismail S, Lughezzani G, Jeldres C, Budaus L, Thuret R, Shariat SF, Widmer H, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI. Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study. BJU Int. 2010 Sep 22.[Epub ahead of print] PMID: 20860649.
73. Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol. 2010 Nov; Epub 2010 Sep 17. PMID: 20846680.
74. Thuret R, Sun M, Lughezzani G, Budaus L, Liberman D, Abdollah F, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI. A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma. Ann Surg Oncol. 2010 Sep 14. [Epub ahead of print] PMID: 20839061.
75. Lughezzani G, Sun M, Shariat SF, Budäus L, Thuret R, Jeldres C, Liberman D, Montorsi F, Perrotte P, Karakiewicz PI. A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer. Cancer. 2010 Aug 27. [Epub ahead of print] PMID: 20803606.
76. Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF, Vickers AJ. Predictive and Prognostic Models in Radical Prostatectomy Candidates: A Critical Analysis of the Literature. Eur Urol. 2010 Aug 6. [Epub ahead of print] PMID: 20727668.
77. Favaretto RL, Shariat SF, Chade DC, Godoy G, Kaag M, Cronin AM, Bochner BH, Coleman J, Dalbagni G. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique? Eur Urol. 2010 Aug 11. [Epub ahead of print] PMID: 20724065.
78. Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Müller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res. 2010 Sep 1;16(17):4461-7. Epub 2010 Jul 22. PMID: 20651056.
79. Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol. 2010 Sep; Erratum in: J Urol. 2010 Nov; PMID: 20643448.
80. Favaretto RL, Shariat SF, Chade DC, Godoy G, Adamy A, Kaag M, Bochner BH, Coleman J, Dalbagni G. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol. 2010 Oct; Epub 2010 Jul 9. PMID: 20637540.
81. Shariat SF, Chade DC, Karakiewicz PI, Scherr DS, Dalbagni G. Update on intravesical agents for non-muscle-invasive bladder cancer. Immunotherapy. 2010 May; Review. PMID: 20635902.
82. Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Sonpavde G, Gupta A, Kassouf W, Fradet Y, Ficarra V, Skinner E, Lotan Y, Sagalowsky AI, Stief CG, Reich O, Shariat SF. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol. 2010 Aug; Epub 2010 Jun 17. PMID: 20620401.
83. Chade DC, Shariat SF, Adamy A, Bochner BH, Donat SM, Herr HW, Dalbagni G. Clinical outcome of primary versus secondary bladder carcinoma in situ. J Urol. 2010 Aug; Epub 2010 Jun 17. PMID: 20620399.
84. Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Shariat SF; Upper Tract Urothelial Carcinoma Collaborative Group. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol. 2010 Aug; Epub 2010 Jun 17. PMID: 20620397.
85. Lotan Y, Shariat SF, Schmitz-Dräger BJ, Sanchez-Carbayo M, Jankevicius F, Racioppi M, Minner SJ, Stöhr B, Bassi PF, Grossman HB. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. Urol Oncol. 2010 Jul-Aug; PMID: 20610281.
86. Shariat SF, Lotan Y, Vickers A, Karakiewicz PI, Schmitz-Dräger BJ, Goebell PJ, Malats N. Statistical consideration for clinical biomarker research in bladder cancer. Urol Oncol. 2010 Jul-Aug; Review. PMID: 20610277.
87. Sun M, Shariat SF, Karakiewicz PI. Factors affecting outcome in renal cell carcinoma. Curr Opin Urol. 2010 Sep; Review. PMID: 20592610.
88. Jeldres C, Sun M, Lughezzani G, Isbarn H, Shariat SF, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer. 2010 Aug 5; PMID: 20564085.
89. Chade DC, Shariat SF, Godoy G, Savage CJ, Cronin AM, Bochner BH, Donat SM,Herr HW, Dalbagni G. Clinical outcomes of primary bladder carcinoma in situ in a contemporary series. J Urol. 2010 Jul; PMID: 20546806.
90. Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol. 2010 Jul; Epub 2010 May 15. PMID: 20478585.
91. Bigot P, Bernhard JC, Crepel M, Bensalah K, Azzouzi AR, de la Taille A, Salomon L, Tostain J, Ficarra V, Pantuck AJ, Belldegrun AS, Méjean A, Ferrière JM, Pfister C, Albouy B, Colombel M, Zini L, Villers A, Montorsi F, Shariat S, Rioux-Leclercq N, Patard JJ. [How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?]. Prog Urol. 2010 May; Epub 2010 Mar 29. French. PMID: 20471579.
92. Wheat JC, Weizer AZ, Wolf JS Jr, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewicz P, Capitanio U, Bensalah K, Patard JJ, Shariat SF. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol. 2010 May 5. [Epub ahead of print] PMID: 20451416.
93. Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, Dinney CP, Lerner SP, Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010 Jun; PMID: 20399473.
94. Shariat SF, Tilki D. Bladder cancer: Nomogram aids clinical decision making after radical cystectomy. Nat Rev Urol. 2010 Apr; PMID: 20383183.
95. Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol. 2010 May; Epub 2010 Mar 17. PMID: 20299059.
96. Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y. Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. J Urol. 2010 May; Epub 2010 Mar 17. PMID: 20299037.
97. Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH, Donat SM, Herr HW, Dalbagni G, Sandhu JS. Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol. 2010 May; Epub 2010 Mar 17. PMID: 20299035.
98. Lughezzani G, Sun M, Budäus L, Thuret R, Shariat SF, Perrotte P, Karakiewicz PI. Effect of the number of biopsy cores on prostate cancer detection and staging. Future Oncol. 2010 Mar; Review. PMID: 20222795.
99. Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budaus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol. 2010 Apr; Epub 2010 Feb 19. PMID: 20171666.
100. Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int. 2010 May; Epub 2010 Feb 2. PMID: 20132195.
101. Bhojani N, Capitanio U, Suardi N, Jeldres C, Isbarn H, Shariat SF, Graefen M, Arjane P, Duclos A, Lattouf JB, Saad F, Valiquette L, Montorsi F, Perrotte P, Karakiewicz PI. The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys. 2010 Feb 1; PMID: 20117287.
102. Tilki D, Reich O, Karakiewicz PI, Novara G, Kassouf W, Ergün S, Fradet Y, Ficarra V, Sonpavde G, Stief CG, Skinner E, Svatek RS, Lotan Y, Sagalowsky AI, Shariat SF. Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome. Eur Urol. 2010 Jul; Epub 2010 Jan 20. PMID: 20097469.
103. Bolenz C, Shariat SF, Karakiewicz PI, Ashfaq R, Ho R, Sagalowsky AI, Lotan Y. Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder. BJU Int. 2010 Jan 19. [Epub ahead of print] PMID: 20089105.
104. Baillargeon-Gagné S, Jeldres C, Lughezzani G, Sun M, Isbarn H, Capitanio U, Shariat SF, Crépel M, Alasker A, Widmer H, Arjane P, Patard JJ, Perrotte P, Montorsi F, Graefen M, Karakiewicz PI. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma. BJU Int. 2010 Feb; PMID: 20089096.
105. Sun M, Lughezzani G, Alasker A, Isbarn H, Jeldres C, Shariat SF, Budäus L, Lattouf JB, Valiquette L, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection. J Urol. 2010 Mar; Epub 2010 Jan 18. PMID: 20083257.
106. Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010 Jun; Epub 2010 Jan 6. PMID: 20071073.
107. Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V; for the Upper-Tract Urothelial Carcinoma Collaborative Group. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol. 2010 Jan 5. [Epub ahead of print] PMID: 20056458.
108. Shariat SF, Karam JA, Karakiewicz PI. Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007; Eur Urol. 2009 Jan; PMID: 20050019.
109. Shariat SF, Hammerich KH. Words of wisdom. Re: Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol 2008; discussion 1837. Eur Urol. 2009 Jan; PMID: 20050015.
110. Lughezzani G, Sun M, Perrotte P, Jeldres C, Alasker A, Isbarn H, Budäus L, Shariat SF, Guazzoni G, Montorsi F, Karakiewicz PI. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer. 2010 Mar; Epub 2010 Jan 13. PMID: 20044246.
111. Chade DC, Shariat SF, Dalbagni G. Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review. Int Braz J Urol. 2009 Nov-Dec; discussion 651. PMID: 20028569.
112. Lughezzani G, Sun M, Jeldres C, Alasker A, Budäus L, Shariat SF, Latour M, Widmer H, Duclos A, Jolivet-Tremblay M, Montorsi F, Perrotte P, Karakiewicz PI. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Urology. 2010 Feb; PMID: 20022091.
113. Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budaus L, Alasker A, Duclos A, Widmer H, Latour M, Guazzoni G, Montorsi F, Karakiewicz PI. Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study. Eur Urol. 2010 Jun; Epub 2009 Dec 10. PMID: 20018438.
114. Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU Int. 2010 Aug; Epub 2009 Dec 11. PMID: 20002664.
115. Shariat SF, Kattan MW, Vickers AJ, Karakiewicz PI, Scardino PT. Critical review of prostate cancer predictive tools. Future Oncol. 2009 Dec; Review. PMID: 20001796.
116. Jeldres C, Sun M, Isbarn H, Lughezzani G, Budäus L, Alasker A, Shariat SF, Lattouf JB, Widmer H, Pharand D, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology. 2010 Feb; Epub 2009 Dec 6. PMID: 19963237.
117. Crépel M, Jeldres C, Perrotte P, Capitanio U, Isbarn H, Shariat SF, Liberman D, Sun M, Lughezzani G, Arjane P, Widmer H, Graefen M, Montorsi F, Patard JJ, Karakiewicz PI. Nephron-sparing surgery is equally effective to radical nephrectomy for T1bN0M0 renal cell carcinoma: a population-based assessment. Urology. 2010 Feb; Epub 2009 Dec 4. PMID: 19962740.
118. Lughezzani G, Sun M, Perrotte P, Shariat SF, Jeldres C, Budäus L, Latour M, Widmer H, Duclos A, Bénard F, McCormack M, Montorsi F, Karakiewicz PI. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Urology. 2010 Feb; Epub 2009 Dec 4. PMID: 19962727.
119. Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernández MI, Wood CG, Montorsi F, Ströbel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010 Apr; Epub 2009 Nov 25. PMID: 19959276.
120. Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol. 2010 Jan; Epub PubMed PMID: 19942232.
121. Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Lerner SP, Sagalowsky AI, Cote RJ, Lotan Y. Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer. J Urol. 2010 Jan; Epub. PMID: 19913255.
122. Shariat SF, Godoy G, Lotan Y, Droller M, Karakiewicz PI, Raman JD, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Wheat JC, Zigeuner R, Langner C, Wood CG, Margulis V. Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy. BJU Int. 2010 Jun; Epub 2009 Nov 13. PMID: 19912201.
123. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010 Feb;105(3):300-8. Epub 2009 Nov 13. Review. PMID: 19912200.
124. Shariat SF, Karakiewicz PI, Godoy G, Karam JA, Ashfaq R, Fradet Y, Isbarn H, Montorsi F, Jeldres C, Bastian PJ, Nielsen ME, Müller SC, Sagalowsky AI, Lotan Y. Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clin Cancer Res. 2009 Nov 15; Epub 2009 Nov 10. PMID: 19903782.
125. Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewicz P, Suardi N, Remzi M, Zigeuner R, Bolenz C, Kikuchi E, Weizer A, Bensalah K, Sagalowsky A, Koppie TM, Raman J, Fernández M, Ströbel P, Kabbani W, Langner C, Wheat J, Guo CC, Kassouf W, Haitel A, Wood CG, Montorsi F. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology. 2009 Nov; PMID: 19883824.
BOOK CHAPTERS
1. Chromecki T. and Shariat S.: Upper tract urothelial carcinoma.In Textbook of Urologic Oncology. Spiess P. (eds), 2011.
2. Bensalah K., Shariat S., Patard J.: Prognostic factors for localized and metastatic renal cell carcinoma. In Recent Advanced In Renal Cell Carcinoma. Molins J. (eds), 2008.
3. Shariat S. and Roehrborn C.: Prostate cancer detection. In: Textbook of Prostate Cancer. Su L. (eds), 2008.
4. Shariat S. and Kattan M.: Nomograms for prostate cancers. In: Textbook of Prostate Cancer. Thompson I. (eds), 2008.
5. Shariat S. and Kattan M.: Risk assessment in prostate cancers. In: Textbook of Prostate Cancer. Tewari A. (eds). Springer Verlag, Germany, 2008.
6. Shariat S., Canto E., Slawin K.: Molecular genetics of BPH. In: Textbook of Benign Prostatic Hyperplasia. Chapter 9, Vol.2. Kirby R., McConnell J., Fitzpatrick J., Roehrborn C., Boyle P. (eds). Oxford, UK, Isis Medical Media Ltd, 2005.
7. M.Sun, S.Shariat, C. Cheng, V. Ficarra, M. Murai, S. Oudard, A.J. Pantuck, R. Zigeuner, P.I. Karakiewicz: Prognostic factors of renal cell carcinoma: A contemporary review. Kidney Cancer, (Eds: Z. Kirkali and P. Mulders) 2011 Edition, page 75-98.
